NAACCR Item #3921: Residual Tumor Volume Post Cytoreduction

Item # Length Source of Standard Year Implemented Version Implemented Year Retired Version Retired
3921 2 NAACCR 2018 18

NAACCR XML: Tumor.residualTumVolPostCytoreduction

Gross residual tumor after primary cytoreductive surgery is a prognostic factor for ovarian cancer and residual tumor volume after cytoreductive surgery is a prognostic factor for late stage ovarian cancers.
Residual Tumor Volume Post Cytoreduction is a Registry Data Collection Variable listed in AJCC. It was previously collected as Ovary, CS SSF # 3.
00No gross residual tumor nodules
50Residual tumor nodule(s) 1 centimeter (cm) or less
60Residual tumor nodule(s) greater than 1 cm
70Macroscopic residual tumor nodule(s), size not stated
80Procedure described as optimal debulking and size of residual tumor nodule(s) not given
97No cytoreductive surgery performed
98Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of code 98 will result in an edit error.)
99Not documented in medical record
Residual tumor status after cytoreductive surgery not assessed or unknown if assessed
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.